维普中文期刊产品整合服务
76篇 您的检索式:作者名="Glintborg D"
    题名 作者 年代 出处 被引量
1lntact primary mitochondrial function in myotubes established from women with PCOS显示文摘Eriksen MB Miner AD Glintborg D 2011J Clin Endocrinol Metab2011,96,8:1
2Thiazolinedione treatment in PCOS-an update显示文摘Glintborg D Andersen M 2010Gynecol Endocrinol2010,26,11:1
3An update on the pathogenesis, in- flammation, and metabolism in hirsutism and polycystic ovary syndrome 显示文摘Glintborg D Andersen M 2010Gynecol Endocrinol2010,26,:1
4Association of pioglitazone treatment with decreased bone mineral den- sity in obese premenopausal patients with polycystic o- vary syndrome: a randomized, placebo-controlled trial 显示文摘Glintborg D Andersen M Hagen C 2008Clin Endocrinol Metab2008,93,:1
5An update On pathogenesis,Inflammation,and metabolism in hirsutism and polycystic ovary syndrome显示文摘Glintborg D Andersen M 2010Gynecol Endocrino12010,26,4:1
6Impaired insulinstimulated phosphorylation of Akt and AS160 in skeletal muscle of women with polycystic ovary syndrome is reversed by pioglitazone treatment显示文摘Hojlund K Glintborg D Andersen NR 2008Diabetes2008,57,2:1
7Thiazolinedione treatment in PCOS anupdate显示文摘Glintborg D Andersen M 2010Gynecol Endocrinol2010,26,11:1
8An update on the pathogenesis inflammation and metabolism in hirsutism and polycystic ovary syndrome显示文摘Glintborg D Andersen M 2010Gynecol Endocrinol2010,26,4:1
9Association of pioglitazone treat- ment with decreased bone mineral density in obese premenopausal patients with polycystic ovary syn- drome: a randomized, placebo-con- trolled trial 显示文摘Glintborg D Andersen M Hagen C 2008J Clin EndocrinolMetab2008,93,5:1
10Association of pioglitazone treatment with decreased bone mineral density in obese premenopausal patients with polycystic ovary syndrome: a randomized, placebo-controlled trial 显示文摘Glintborg D Andersen M Hagen C 2008J Clin Endocrinol Metab2008,93,:1
11Reduced expression of nuclear-encoded genes involved in mitochondrial oxidative metabolism in skeletal muscle of insulin-resistant women with polycystic ovary syndrome显示文摘Skov V Glintborg D Knudsen S 2007Diabetes2007,56,9:1
12Soluble CD36 and risk markers of insulin resistance and atherosclerosis are elevated in polycystie ovary syndrome and significantly reduced during pioglitazone treatment 显示文摘Glintborg D Hojlund K Andersen M 2008Diabetes Care2008,31,2:1
13An update on the pathogenesis inflammation and metabolism in hirsutism an polycystic o- vary syndrome 显示文摘Glintborg D Andersen M 2010Gynecol Endocrinol2010,26,4:1
14An update on the pathogenesis, inflammation, and metabolism in hirsutism and polycystic ovary syndrome 显示文摘Glintborg D Andersen M 2010Gynecol Endocrinol2010,26,4:1
15Reduced expression of nuclear-encoded genes involved in mitochondrial oxidative metabolism in skeletal muscle of insulin-resistant women with polycystic ovary syndrome显示文摘Skov V Glintborg D Knudsen S 2007Diabetes2007,56,9:1
16Intact primary mitochondrialfunction in myotubes established from women with PCOS显示文摘Eriksen MB Minet AD Glintborg D 2011J Clin En-docrinol Metab2011,96,8:1
17An update on the pathogenesis, inflammation, and metabolism in hirsutism and polycystic ovary syndrome显示文摘Glintborg D Andersen M 2010Gynecol Endoerinol2010,26,4:1
18Smoking is asso- ciated with increased adrenal responsiveness,decreased prolac- tin levels and a more adverse lipid profile in 650 white patients with polycystic ovary syndrome 显示文摘Glintborg D Mumm H Hougaard DM 2011Gynecol Endocrinol2011,,:1
19An update on the pathogenesis, inflammation, and metabolism in hirsutism and polycystic ovary syndrome显示文摘Glintborg D Andersen M 2010Gynecol Endocrinol2010,26,:1
20An update on the pathogenesis,inflammation,and metabolism in hirsutism and polycystic ovary syndrome显示文摘Glintborg D Andersen M 2010Gynecol Endocrinol2010,26,4:1
返回顶部 每页显示:
共4页 首页 上一页 第1页 下一页 末页 /4 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费